Sigyn Therapeutics (SIGY) EBITDA (2017 - 2025)
Sigyn Therapeutics' (SIGY) quarterly EBITDA came in at -$386529.0 in Q3 2025, up 52.19% year-over-year from -$253979.0 in Q3 2024, and up 17.67% quarter-over-quarter from -$469513.0 in Q2 2025.
Powered by 
Analysis
Sigyn Therapeutics (SIGY) EBITDA (2017 - 2025) Analysis & Trends
Sigyn Therapeutics has disclosed EBITDA across 9 years of filings, most recently posting -$386529.0 for Q3 2025.
- In Q3 2025, EBITDA rose 52.19% year-over-year to -$386529.0; the TTM figure through Sep 2025 stood at -$1.9 million (up 31.84% YoY), while the FY2024 annual figure was -$2.5 million, down 2.6% from the prior year.
- EBITDA came in at -$386529.0 for Q3 2025 at Sigyn Therapeutics, up from -$469513.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$386529.0 in Q3 2025 to a low of -$808458.0 in Q3 2024.
- Average EBITDA over 5 years is -$554323.4, with a median of -$546059.0 recorded in 2025.
- Year-over-year, EBITDA sank 182.48% in 2021 and soared 52.19% in 2025.
- Over 5 years, EBITDA stood at -$590939.0 in 2021, then increased by 20.2% to -$471588.0 in 2022, then slumped by 52.09% to -$717236.0 in 2023, then soared by 33.35% to -$478010.0 in 2024, then increased by 19.14% to -$386529.0 in 2025.
- Per Business Quant data, the three most recent EBITDA figures were -$386529.0 in Q3 2025, -$469513.0 in Q2 2025, and -$546059.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 971.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.76 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.18 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 513.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 11.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 318.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | -386,529.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -386,529.00 |
| Jun 30, 2025 | -469,513.00 |
| Mar 31, 2025 | -546,059.00 |
| Dec 31, 2024 | -478,010.00 |
| Sep 30, 2024 | -808,458.00 |
| Jun 30, 2024 | -602,805.00 |
| Mar 31, 2024 | -629,972.00 |
| Dec 31, 2023 | -717,236.00 |
| Sep 30, 2023 | -642,814.00 |
| Jun 30, 2023 | -574,009.00 |
| Mar 31, 2023 | -521,258.00 |
| Dec 31, 2022 | -471,588.00 |
| Sep 30, 2022 | -533,647.00 |
| Jun 30, 2022 | -532,795.00 |
| Mar 31, 2022 | -609,236.00 |
| Dec 31, 2021 | -590,939.00 |
| Sep 30, 2021 | -573,363.00 |
| Jun 30, 2021 | -441,818.00 |
| Mar 31, 2021 | -402,096.00 |
| Dec 31, 2020 | -344,567.00 |